Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.162
Peer-review started: August 16, 2016
First decision: September 2, 2016
Revised: December 30, 2016
Accepted: January 11, 2017
Article in press: January 14, 2017
Published online: April 16, 2017
Processing time: 244 Days and 9 Hours
To compare the impact of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) on weight loss and obesity related comorbidities over two year follow-up via case control study design.
Forty patients undergoing LRYGB, who completed their two year follow-up were matched with 40 patients undergoing LSG for age, gender, body mass index and presence of type 2 diabetes mellitus (T2DM). Data of these patients was retrospectively reviewed to compare the outcome in terms of weight loss and improvement in comorbidities, i.e., T2DM, hypertension (HTN), obstructive sleep apnea syndrome (OSAS), hypothyroidism and gastroesophageal reflux disease (GERD).
Percentage excess weight loss (EWL%) was similar in LRYGB and LSG groups at one year follow-up (70.5% vs 66.5%, P = 0.36) while it was significantly greater for LRYGB group after two years as compared to LSG group (76.5% vs 67.9%, P = 0.04). The complication rate after LRYGB and LSG was similar (10% vs 7.5%, P = 0.99). The median duration of T2DM and mean number of oral hypoglycemic agents were higher in LRYGB group than LSG group (7 years vs 5 years and 2.2 vs 1.8 respectively, P < 0.05). Both LRYGB and LSG had significant but similar improvement in T2DM, HTN, OSAS and hypothyroidism. However, GERD resolved in all patients undergoing LRYGB while it resolved in only 50% cases with LSG. Eight point three percent patients developed new-onset GERD after LSG.
LRYGB has better outcomes in terms of weight loss two years after surgery as compared to LSG. The impact of LRYGB and LSG on T2DM, HTN, OSAS and hypothyroidism is similar. However, LRYGB has significant resolution of GERD as compared to LSG.
Core tip: Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) are the most popular bariatric procedures. Few studies have compared the outcomes of LSG vs LRYGB in terms of weight loss and comorbidity resolution, especially in India. Using case control design in a well-matched population of 40 patients each undergoing LSG and LRYGB, we found similar weight loss one year after surgery in both the groups but the weight loss was significantly higher in LRYGB group two years after surgery. The complication rate was similar in both groups. Regarding comorbidity resolution, both LRYGB and LSG had significant but similar impact on obesity related comorbidities except gastroesophageal reflux disease where LRYGB showed better improvement. This is also among the first few studies to study the impact of bariatric surgery on hypothyroidism.